Kappos, L. Et Al. 2012. Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study. MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3 , 314-321.

Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., ... Polman, C. H.(2012). Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study. MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3, 314-321.

Kappos, Ludwig Et Al. "Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study," MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3, 314-321, 2012

Kappos, Ludwig Et Al. "Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study." MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3, pp.314-321, 2012

Kappos, L. Et Al. (2012) . "Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study." MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3, pp.314-321.

@article{article, author={Ludwig Kappos Et Al. }, title={Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2012, pages={314-321} }